Optimal drugs concentrations and doses for allergological diagnostics of perioperative drugs hypersensitivity reactions

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


Background. The study aimed to develop the optimal concentration and doses of drugs for examination of perioperative drug’s hypersensitivity reactions. Methods. The protocol of allergological examination included clinical, laboratory methods and tests in vivo: skin tests (prick-, intradermal, patch- test) with neuromuscular blockers, opioids, radiocontrast medias, colloids, hypnotics; patch-test with povidon-iodine, chlorhexidine; dosing provocative test (including investigation of blood, nasal secretion eosinophilia, serum tryptase measurements) with antibiotics, nonsteroid anti-inflammatory drugs, local anesthetics. 20 healthy volunteers were included in the study during 2 years (2010-2012) for estimating of the doses and concentrations of testing drugs. Results. Non irritating concentrations for skin tests (prick- and intradermal) with perioperative drugs have been estimated on healthy controls. No one of healthy controls had false positive tests and nonspecific histamine-release effects while testing in vivo. Increased tryptase level 1 h after and the level of blood eosinophilia and eosinophiliaof nasal secretion 6 hours after dosing provocation test with each drug were found to be statistically insignificant. Conclusions. Optimal concentrations and doses of drugs for allergological examination of perioperative drug’s hypersensitivity reactions were estimated.

Full Text

Restricted Access

About the authors

D G Zhukova

Central clinical hospital of the Russian Academy of sciences

Email: zulyaevan@mail.ru

E S Fedenko

Institute of Immunology

A A Yudin

Central clinical hospital of the Russian Academy of sciences; Pirogov Russian National Research Medical university


  1. Manfredi G., Pezzuto F., Balestrini A. et al. Perioperative Anaphylactic Risk Score For Risk-Oriented Premedication Translational Medicine. 2013, v. 7, p. 12-17.
  2. Axon A.D. Anaphylaxis and anesthesia - all clear now? British Journal of Anaesthesia. 2004, v. 93, p. 501-504.
  3. Mertes P.M., Malinovsky J.M., Jouffroy L. et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J. Investig. Allergol. Clin. Immunol. 2011, v. 21, p. 442-453.
  4. Адо А.Д., Порошина Ю.А., Лусс Л.В. и соавт. Тест торможения естественной эмиграции лейкоцитов in vivo (ТТЕЭЛ) для специфической диагностики лекарственной аллергии (методические рекомендации). М., 1986, 10 с.
  5. Celik G., Pichler W.J., Adkinson N.F. et al. Drug Allergy. In: Middleton’s Allergy Principles and Practice, 7th ed., Philadelphia, Mosby Elsevier. 2009, v. 1, p. 1205-1226.
  6. Жукова Д.Г., Феденко Е.С., Юдин А.А., Цывкина Е.А. Оценка риска реакций гиперчувствительности к лекарственным средствам в периоперационном периоде с помощью специализированного опросника. Рос. Аллергол. Журн. 2014, № 4, с. 18-25.
  7. Хаитов Р.М., Ильина Н.И. Федеральные клинические рекомендации по аллергологии. М., «Фармарус-Принт». 2014, 123 c.
  8. Simons F.E., Ardusso L.R., Bilo M.B. et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 201l, v. 4, p. 13-37.
  9. Хаитов Р.М. Клиническая аллергология. М., «МЕДпресс-информ». 2002, 624 c.
  10. Aberer W., Bircher A., Romano A. et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003, v. 58, p. 854-863.
  11. Chaudhry T., Hissaria P., Wiese M. et al. Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis. Intern. Med. J. 2012, v. 42, p. 665-671.
  12. Gollapudi R.R., Teirstein P.S., Stevenson D.D., Simon R.A. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA. 2004, v. 292, p. 3017-3023.
  13. Messaad D., Sahla H., Benahmed S. et al. Drug Provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann. Inter. Med. 2004, v. 140, p. 1001-1006.
  14. Schatz M. Adverse reactions to local anesthetics. Immunol. All. Clin. N. Am. 1992, v. 12, p. 585-609.
  15. Solensky R., Khan D.A. Drug Allergy: An Updated Practice Parameter. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology. Ann. Allergy Asthma Immunol. 2010, v. 105, p. 259-273.
  16. UniCAP Tryptase Fluoroenzymeimmunoassay. Instruction Manual, Pharmacia and UpJohn, Uppsala, Sweden. 2001, р. 2-3.
  17. Адо А.Д. Применение аллергенов неинфекционного происхождения для специфической диагностики и десен сибилизации больных аллергическими заболеваниями. Методическое письмо. М., МЗ СССР. 1969, 26 с.
  18. Федеральный закон № 3 от 8 января 1998 года (в ред. от 25.11.2013 № 317-ФЗ, с изм., внесенными от 04.06.2014 № 145-ФЗ) «О наркотических средствах и психотропных веществах». Avaiable at: http://base.consultant.ru/cons/cgi/ online.cgi?base=LAW&n=154942&req=doc.
  19. Kroigaard M., Garvey L.H., Gillberg L. et al. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anesthesia. Acta Anaesthesiol. Scand. 2007, v. 51, p. 655-670.



Abstract: 128

PDF (Russian): 1

Article Metrics

Metrics Loading ...



Copyright © Pharmarus Print Media, 2015

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies